切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2021, Vol. 15 ›› Issue (01) : 70 -74. doi: 10.3877/cma.j.issn.1674-0793.2021.01.018

所属专题: 文献

综述

经皮机械性血栓清除术治疗下肢深静脉血栓形成的研究进展
李观强1, 孙元2, 张喜成2,()   
  1. 1. 116044 大连医科大学研究生院;225001 扬州,江苏省苏北人民医院血管外科
    2. 225001 扬州,江苏省苏北人民医院血管外科
  • 收稿日期:2020-08-29 出版日期:2021-02-01
  • 通信作者: 张喜成

Advances of percutaneous mechanical thrombectomy in the treatment of lower extremity deep vein thrombosis

Guanqiang Li1, Yuan Sun2, Xicheng Zhang2,()   

  1. 1. Graduate School of Dalian Medical University, Dalian 116044, China; Department of Vascular Surgery, Northern Jiangsu People’s Hospital, Yangzhou 225001, China
    2. Department of Vascular Surgery, Northern Jiangsu People’s Hospital, Yangzhou 225001, China
  • Received:2020-08-29 Published:2021-02-01
  • Corresponding author: Xicheng Zhang
引用本文:

李观强, 孙元, 张喜成. 经皮机械性血栓清除术治疗下肢深静脉血栓形成的研究进展[J]. 中华普通外科学文献(电子版), 2021, 15(01): 70-74.

Guanqiang Li, Yuan Sun, Xicheng Zhang. Advances of percutaneous mechanical thrombectomy in the treatment of lower extremity deep vein thrombosis[J]. Chinese Archives of General Surgery(Electronic Edition), 2021, 15(01): 70-74.

静脉血栓栓塞症发病率逐渐增加,即使是在标准抗凝治疗下,仍然有70%以上的患者会发生血栓形成后综合征(PTS),这将严重降低患者生活质量,增加经济负担。因此,快速去除血栓,恢复静脉通路,减少PTS的发生成为近年来临床关注的重点。目前的治疗方法有系统溶栓、导管接触性溶栓(CDT)、手术取栓、血栓抽吸、经皮机械取栓(PMT)等,其中PMT可通过不同物理方法快速清除血栓,减少溶栓药物的使用,虽然目前尚无高质量证据证明其相对于其他方式有更好的安全性及有效性,但PMT为临床医师提供了更多的选择,从而实现个体化医疗,获得最佳的临床效果。本文旨在对目前常见的PMT在原理、特点及局限性等方面进行综述。

The incidence of venous thromboembolism is gradually increasing. More than 70% of patients receiving standard anticoagulation treatment suffered from post-thrombotic syndrome (PTS), which will seriously reduce the quality of life and increase the economic burden. Therefore, rapid removal of thrombus, restoration of venous flow and reduce the incidence of PTS have become the focus of clinical research in recent years. The current treatment methods include systemic thrombolysis, catheter-directed thrombolysis (CDT), surgical thrombectomy, thrombus aspiration, percutaneous mechanical thrombectomy (PMT), et al. PMT can rapidly remove acute or subacute thrombus through different physical methods and reduce the use of thrombolytic drugs. Although there is no high-quality evidence to prove that PMT has better safety and effectiveness than other treatments, it provides more choices for clinicians to achieve the best clinical effects. This paper aims to summarize the basic principles, advantages and limitations of PMT.

表1 不同方式的经皮机械取栓(PMT)特点及局限性
[1]
Heit JA, Spencer FA, White RH. The epidemiology of venous thromboembolism[J]. J Thromb Thrombolysis, 2016, 41(1): 3-14.
[2]
Galanaud JP, Monreal M, Kahn SR. Epidemiology of the post-thrombotic syndrome[J]. Thromb Res, 2018, 164: 100-109.
[3]
Calik ES, Dag O, Kaygin MA, et al. Pharmacomechanical thrombectomy for acute symptomatic lower extremity deep venous thrombosis[J]. Heart Surg Forum, 2015, 18(4): E178-E183.
[4]
Jenkins JS. Endovascular therapies to treat iliofemoral deep venous thrombosis[J]. Prog Cardiovasc Dis, 2011, 54(1): 70-76.
[5]
Blackwood S, Dietzek AM. Pharmacomechanical thrombectomy: 2015 update[J]. Expert Rev Cardiovasc Ther, 2016, 14(4): 463-475.
[6]
Shi HJ, Huang YH, Shen T, et al. Percutaneous mechanical thrombectomy combined with catheter-directed thrombolysis in the treatment of symptomatic lower extremity deep venous thrombosis[J]. Eur J Radiol, 2009, 71(2): 350-355.
[7]
Shi HJ, Huang YH, Shen T, et al. Percutaneous mechanical thrombectomy for acute massive lower extremity deep venous thrombosis[J]. Surg Laparosc Endosc Percutan Tech, 2011, 21(1): 50-53.
[8]
Gagne P, Khoury T, Zadeh BJ, et al. A multicenter, retrospective study of the effectiveness of the Trellis-8 system in the treatment of proximal lower-extremity deep vein thrombosis[J]. Ann Vasc Surg, 2015, 29(8): 1633-1641.
[9]
Mahmoud O, Vikatmaa P, Räsänen J, et al. Catheter-directed thrombolysis versus pharmacomechanical thrombectomy for upper extremity deep venous thrombosis: A cost-effectiveness analysis[J]. Ann Vasc Surg, 2018, 51: 246-253.
[10]
Yuksel A, Tuydes O. Midterm outcomes of pharmacomechanical thrombectomy in the treatment of lower extremity deep vein thrombosis with a rotational thrombectomy device[J]. Vasc Endovascular Surg, 2017, 51(5): 301-306.
[11]
Lichtenberg M, Breuckmann F, Kramer V, et al. Effectiveness of the Pulsar-18 self-expanding stent with optional drug-coated balloon angioplasty in the treatment of femoropopliteal lesions - the BIOFLEX PEACE All-Comers Registry[J]. Vasa, 2019, 48(5): 425-432.
[12]
Song XJ, Liu ZL, Zeng R, et al. The efficacy and safety of AngioJet rheolytic thrombectomy in the treatment of subacute deep venous thrombosis in lower extremity[J]. Ann Vasc Surg, 2019, 58: 295-301.
[13]
Liu G, Zhao Z, Cui C, et al. Endovascular management of extensive lower extremity acute deep vein thrombosis with AngioJet rheolytic thrombectomy plus catheter-directed thrombolysis from contralateral femoral access[J]. Phlebology, 2019, 34(4): 257-265.
[14]
Dumantepe M, Uyar I. The effect of Angiojet rheolytic throm-bectomy in the endovascular treatment of lower extremity deep venous thrombosis[J]. Phlebology, 2018, 33(6): 388-396.
[15]
Biederer J, Charalambous N, Paulsen F, et al. Treatment of acute pulmonary embolism: local effects of three hydrodynamic thrombectomy devices in an ex vivo porcine model[J]. J Endovasc Ther, 2006, 13(4): 549-560.
[16]
Angle JF, Spinosa DJ, Hagspiel KD, et al. Management of acute lower extremity embolus with use of the oasis thrombectomy device and suction embolectomy[J]. J Vasc Interv Radiol, 2000, 11(10): 1331-1335.
[17]
Tsuji A, Yamada N, Ota S, et al. Early results of rheolytic thrombectomy in patients with proximal deep vein thrombosis[J]. Circ J, 2011, 75(7): 1742-1746.
[18]
丁锦辉,丁贺义,蒋米尔. 下肢深静脉血栓腔内治疗进展[J]. 临床外科杂志, 2016, 24(8): 638-640.
[19]
Francis CW, Onundarson PT, Carstensen EL, et al. Enhancement of fibrinolysis in vitro by ultrasound[J]. J Clin Invest, 1992, 90(5): 2063-2068.
[20]
李晓强,周为民,余朝文, 等. 超声消融球囊扩张联合动静脉瘘治疗下肢深静脉血栓[J]. 解剖与临床, 2005, 10(1): 38-39, 44.
[21]
Notten P, Ten Cate-Hoek AJ. Catheter interventions: an unresolved clinical controversy - Authors’ reply[J]. Lancet Haematol, 2020, 7(3): e190.
[22]
Lu T, Loh TM, El-Sayed HF, et al. Single-center retrospective review of ultrasound-accelerated versus traditional catheter-directed thrombolysis for acute lower extremity deep venous thrombosis[J]. Vascular, 2017, 25(5): 525-532.
[23]
Wildberger JE, Schmitz-Rode T, Haage P, et al. Ultrasound thrombolysis in hemodialysis access: in vitro investigation[J]. Cardiovasc Intervent Radiol, 2001, 24(1): 53-56.
[24]
Fischell TA, Haddad N, Baskerville S, et al. Ultrasound throm-bolysis for the treatment of thrombotic occlusion of degenerated saphenous vein grafts[J]. Catheter Cardiovasc Interv, 2000, 50(1): 90-95.
[25]
Vedantham S, Goldhaber SZ, Julian JA, et al. Pharmacomechanical catheter-directed thrombolysis for deep-vein thrombosis[J]. N Engl J Med, 2017, 377(23): 2240-2252.
[26]
Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest, 2008, 133(6 Suppl): 454S-545S.
[27]
Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST Guideline and expert panel report[J]. Chest, 2016, 149(2): 315-352.
[28]
Yin SW, Guo LW, Bian L, et al. Evaluation of percutaneous mechanical thrombectomy via the AngioJet system combined with catheter-directed thrombolysis for the treatment of symptomatic lower extremity deep venous thrombosis[J]. Ann Vasc Surg, 2020, 65: 66-71.
[29]
Zhu Y, Li L, Liu Z, et al. Single-stage treatment of AngioJet rheolytic thrombectomy and stenting for iliac vein compression syndrome with secondary acute iliofemoral deep vein thrombosis[J]. Ann Vasc Surg, 2019, 61: 384-393.
[30]
Thomas M, Hollingsworth A, Mofidi R. Endovascular management of acute lower limb deep vein thrombosis: A systematic review and Meta-analysis[J]. Ann Vasc Surg, 2019, 58: 363-370.
[1] 张伟. 牙及牙槽外科:舒适治疗的先锋[J]. 中华口腔医学研究杂志(电子版), 2023, 17(06): 386-388.
[2] 彭旭, 邵永孚, 李铎, 邹瑞, 邢贞明. 结肠肝曲癌的诊断和外科治疗[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 108-110.
[3] 马伟强, 马斌林, 吴中语, 张莹. microRNA在三阴性乳腺癌进展中发挥的作用[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 111-114.
[4] 杨瑞洲, 李国栋, 吴向阳. 腹股沟疝术后感染的治疗方法探讨[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 715-719.
[5] 邱朋, 邓正栋, 王剑明. 肝内胆管结石微创治疗策略[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 591-596.
[6] 杜锡林, 谭凯, 贺小军, 白亮亮, 赵瑶瑶. 肝细胞癌转化治疗方式[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 597-601.
[7] 魏小勇. 原发性肝癌转化治疗焦点问题探讨[J]. 中华肝脏外科手术学电子杂志, 2023, 12(06): 602-607.
[8] 钟广俊, 刘春华, 朱万森, 徐晓雷, 王兆军. MRI联合不同扫描序列在胃癌术前分期诊断及化疗效果和预后的评估[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 378-382.
[9] 单秋洁, 孙立柱, 徐宜全, 王之霞, 徐妍, 马浩, 刘田田. 中老年食管癌患者调强放射治疗期间放射性肺损伤风险模型构建及应用[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 388-393.
[10] 胡宝茹, 尚乃舰, 高迪. 中晚期肝细胞癌的DCE-MRI及DWI表现与免疫治疗预后的相关性分析[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 399-403.
[11] 顾国英, 黄迎春, 刘佳, 居建明, 于国锋, 蒋荣. 个体化肠外营养在肠切除伴肠功能障碍患者中的应用研究[J]. 中华消化病与影像杂志(电子版), 2023, 13(06): 489-493.
[12] 陆志峰, 周佳佳, 梁舒. 虚拟现实技术在治疗弱视中的临床应用研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 891-895.
[13] 李田, 徐洪, 刘和亮. 尘肺病的相关研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(08): 900-905.
[14] 岳瑞雪, 孔令欣, 郝鑫, 杨进强, 韩猛, 崔国忠, 王建军, 张志生, 孔凡庭, 张维, 何文博, 李现桥, 周新平, 徐东宏, 胡崇珠. 乳腺癌HER2蛋白表达水平预测新辅助治疗疗效的真实世界研究[J]. 中华临床医师杂志(电子版), 2023, 17(07): 765-770.
[15] 符梅沙, 周玉华, 李慧, 薛春颜. 淋巴细胞免疫治疗对复发性流产患者外周血T淋巴细胞亚群分布与PD1/PD-L1表达的影响及意义[J]. 中华临床医师杂志(电子版), 2023, 17(06): 726-730.
阅读次数
全文


摘要